English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 20, 2025

Patients Come First spokesperson on drug pricing reform: 'Vulnerable patients are depending on them to fix 340B'

+ Pharmaceuticals
Patient Daily | Mar 20, 2025

Northwestern Medicine partners with Vitestro on robotic phlebotomy innovation

+ Pharmaceuticals
Patient Daily | Mar 19, 2025

Northwestern Medicine hosts open house for Black Maternal Health Week

+ Pharmaceuticals
Patient Daily | Mar 18, 2025

Redler’s LTC Pharmacy Owner on 340B reform: 'Only 35% of participating hospitals and clinics provide service to underserved areas'

Patient Daily | Mar 18, 2025

Cdc plans study on possible vaccine-autism link amid rising rates

+ Pharmaceuticals
Patient Daily | Mar 18, 2025

McGovern Medical School students prepare for pivotal moment on Match Day

+ Community
Patient Daily | Mar 14, 2025

Doctor on weather-related pressure headaches: This could happen 'if you have an underlying chronic sinus disease'

C.D. Marsden | Mar 14, 2025

Solidarity Health to Musk, RFK, Jr: ‘Enforce the CMS Hospital Price Transparency Rule’

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily